Aridis Pharmaceuticals, Inc. (20) | License Agreements (5)

Recent Contracts

Amendment No. 1 to the License Agreement between Medimmune Limited and Aridis Pharmaceuticals, Inc. dated August 9, 2021 (Filed With SEC on August 12, 2021)
License Agreement between Medimmune Limited and Aridis Pharmaceuticals, Inc. dated as of July 12, 2021 (Filed With SEC on July 19, 2021)
Exclusive License Agreement dated September 10, 2020 by and between Aridis Pharmaceuticals, Inc. and UAB Research Foundation (Filed With SEC on November 23, 2020)
License, Development and Commercialization Agreement between Aridis Pharmaceuticals, Inc. and Serum AMR Products, entered into as of September 27, 2019 (Filed With SEC on October 3, 2019)
Option Agreement for Exclusive Product and Platform Technology License between Aridis Pharmaceuticals, Inc. and Serum International BV, dated July 16, 2019 (Filed With SEC on July 30, 2019)